ClinicalTrials.Veeva

Menu

Newborns From Patients Treated With ART (Assisted Reproductive Technology)

Z

Zhengzhou University

Status

Enrolling

Conditions

Health Related

Study type

Observational

Funder types

Other

Identifiers

NCT03993158
RMCZZU-Birth cohort study

Details and patient eligibility

About

The Prospective Cohort Study for Newborns from patients treated with ART was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.

Full description

Since the last twenty years, thousands of babies were born from infertile couples treated in our center. However, the short, and especially the long term prognosis of these children were barely known.

Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. In addition, information of each newborn from our center has also been kept in CCRM/EMRCD. The current project plans to recruit these newborn babies in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for Newborns from patients treated with ART prognosis.

Enrollment

10,000 estimated patients

Sex

All

Ages

Under 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All newborns from patients treated with ART in our center.

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Lanlan Fang, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems